- Home
- TACO vs LRMR Comparison
TACO vs LRMR Comparison
Compare TACO & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.62
Company Overview
Basic Information| Metric | TACO | LRMR |
|---|---|---|
| Founded | 2024 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.1M | 455.8M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | TACO | LRMR |
|---|---|---|
| Price | $10.20 | $4.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 116.3K | ★ 2.5M |
| Earning Date | 01-01-0001 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,368.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.11 | $1.61 |
| 52 Week High | $10.85 | $6.42 |
Technical Indicators
Market Signals| Indicator | TACO | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 50.57 |
| Support Level | $10.16 | $3.09 |
| Resistance Level | $10.50 | $5.37 |
| Average True Range (ATR) | 0.01 | 0.36 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 25.00 | 21.94 |
Price Performance
Historical Comparison TACO
LRMR
About TACO Berto Acquisition Corp. Ordinary Shares
Berto Acquisition Corp is a blank check company.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.